- Home
- NWTG vs SNSE Comparison
NWTG vs SNSE Comparison
Compare NWTG & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NWTG
- SNSE
- Stock Information
- Founded
- NWTG 2018
- SNSE 2005
- Country
- NWTG United States
- SNSE United States
- Employees
- NWTG N/A
- SNSE N/A
- Industry
- NWTG Recreational Games/Products/Toys
- SNSE Biotechnology: Pharmaceutical Preparations
- Sector
- NWTG Consumer Discretionary
- SNSE Health Care
- Exchange
- NWTG Nasdaq
- SNSE Nasdaq
- Market Cap
- NWTG 8.5M
- SNSE 10.2M
- IPO Year
- NWTG N/A
- SNSE 2021
- Fundamental
- Price
- NWTG $1.84
- SNSE $7.85
- Analyst Decision
- NWTG
- SNSE Strong Buy
- Analyst Count
- NWTG 0
- SNSE 4
- Target Price
- NWTG N/A
- SNSE $72.50
- AVG Volume (30 Days)
- NWTG 166.5K
- SNSE 16.1K
- Earning Date
- NWTG 11-14-2025
- SNSE 08-05-2025
- Dividend Yield
- NWTG N/A
- SNSE N/A
- EPS Growth
- NWTG N/A
- SNSE N/A
- EPS
- NWTG N/A
- SNSE N/A
- Revenue
- NWTG $5,560,000.00
- SNSE N/A
- Revenue This Year
- NWTG $98.37
- SNSE N/A
- Revenue Next Year
- NWTG $49.25
- SNSE N/A
- P/E Ratio
- NWTG N/A
- SNSE N/A
- Revenue Growth
- NWTG 304.36
- SNSE N/A
- 52 Week Low
- NWTG $1.35
- SNSE $5.00
- 52 Week High
- NWTG $119.10
- SNSE $17.40
- Technical
- Relative Strength Index (RSI)
- NWTG 58.81
- SNSE 48.99
- Support Level
- NWTG $1.48
- SNSE $7.65
- Resistance Level
- NWTG $2.06
- SNSE $8.69
- Average True Range (ATR)
- NWTG 0.16
- SNSE 0.66
- MACD
- NWTG 0.02
- SNSE 0.02
- Stochastic Oscillator
- NWTG 80.90
- SNSE 31.81
About NWTG Newton Golf Company Inc. Common Stock
Newton Golf Co Inc is a technology-forward golf company dedicated to revolutionizing the sport with cutting-edge, high-performance products. The company's expanding portfolio includes golf shafts, putters, grips, and other golf-related accessories designed for golfers of all skill levels. The company sells its products through e-commerce, distributors, wholesale customers, including pro-shops at golf courses and off-course retailers, sporting goods retailers, online retailers, third-party distributors, and through Club Champion Golf, as well as through mass merchants and corporate customers in the Americas, Asia, and Europe.
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).